Desenvolvimento de potenciais agentes leishmanicidas: benzotiazois inibidores de N-miristoiltransferase

Detalhes bibliográficos
Ano de defesa: 2016
Autor(a) principal: Junqueira, Luis Otavio [UNIFESP]
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de São Paulo
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=3653222
http://repositorio.unifesp.br/handle/11600/46310
Resumo: N-myristoyltransferase is an enzyme responsible for anchoring proteins to the plasma mem- brane through a cotranslational mechanism of lipidation of proteins in eukaryotes. Previous studies have shown the benzothiazolic nucleus as promising for the development of a new class of NMT in- hibitor compounds. In this study, two benzothiazolic analogs were synthetized and tested against Leishmania (Leishmania) amazonensis. The study began with the synthesis of 6-hidroxi- benzotiazolato de etila followed by the alkylation of the 6-hidroxi position of this intermediate with a consecutive reaction of said alkylated intermediate with 3-picolamina or benzilamina. The products obtained had good purity despite the lower yield. It was also proposed the synthesis of a thiazolic de- rivative which would allow the valuation of the influence from the benzothiazolic core flexibility over the leishmanicide biological activity. The compound derived from 3-picolylamine was sent, along with its synthetic intermediates, for biological activity, showing activity in the order of 21,75 µM. The bio- logical activity profile was attributed to the low lipophilicity of the product obtained after the addition of the picolylaminic groups to the structure. The biological analysis of the derivate obtained from the benzylamine might confirm this hypothesis since it is more lipophilic than the 3-picolilamine derivate. Still, the activity shown by the tested compound demonstrates how this class of benzoheterocycles compounds might be promising for the development of new drugs with leishmanicide activity. Theo- retical studies using molecular docking were conducted with LmNMT in the means of assessing the binding of the benzothiazolic compounds that were obtained to this enzyme. The results showed that the benzothiazolic compounds constitute a class of molecules with a potential for interaction with the LmNMT target. The synthesis of flexible thiazolic analogs and finishing up of biological tests consti- tute the perspectives of the present study.